Pleryon is a biotechnology company focused on developing biomaterial-based therapeutics. It advances research from concept to clinic, combining materials science with pharmaceutical development to create healthcare solutions.
Positioned at the intersection of life sciences and specialty chemicals, Pleryon collaborates with industry partners to scale up compliant manufacturing and bring high-value medical materials to market.
Seqens will develop and produce Pleryon's osteoarthritis polymer at its upgraded French facility, enhancing GMP capabilities for medical and pharmaceutical applications.
